In PD with PIGD, pathologically increased GPi-activity is supposed to cause an over-inhibition of the PPN region via GABAergic projections and current therapies attempt to augment the PPN region activity through low frequency DBS [12,13,14]. Here, GPI is linked to Parkinson disease.